MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Data driven analysis for exploring phenotypic differences in patients with Parkinson’s disease with or without genetic mutations.

    A. Mirelman, T. Kozlovski, A. Thaler, A. Mitelpunkt, T. Gurevich, M. Kestenbaum, Z. Gan Or, M. Gana-Weisz, A. Bar-Shira, A. Orr-Urtreger, S. Bressman, K. Marder, M. Marcus-Kalish, Y. Benjamini, N. Giladi (Tel Aviv, Israel)

    Objective: To explore, using a data driven statistical analysis method, discriminating phenotype features of disease in a large group of patients with Parkinson’s disease (PD)…
  • 2017 International Congress

    Dopamine agonist therapy mediates relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease.

    T. Turner, J. Renfroe, V. Hinson (Charleston, SC, USA)

    Objective: Evaluate relationship between psychomotor inhibition and behavioral impulsivity in Parkinson’s disease (PD). Background: Impulse control disorders can be challenging iatrogenic effects of dopamine agonist…
  • 2017 International Congress

    The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

    V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)

    Objective: To assess whether a functional dysregulation of the habenula and amygdala, as modulators of the reward brain circuit, contributes to Parkinson’s disease (PD)-punding. Background:…
  • 2017 International Congress

    Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test

    S.-k. Song, J.-H. Kang (Jejusi, Republic of Korea)

    Objective: To objectively assess the bradykinesia of upper extremity using the Objective Movement Disorder Measurement (OMDM)-Dexterity test Background: Bradykinesia is one of the clinical hallmarks…
  • 2017 International Congress

    Beyond shuffling: Gait phenotypes in Parkinson’s Disease

    L. Solis-Cohen, C. Ashton, D. Simon, M. Fox, D. Tarsy, R. Alterman, V. Vanderhorst, L. Shih (Boston, MA, USA)

    Objective: To describe commonly observed gait phenotypes in a cohort of advanced Parkinson's Disease (PD) patients. Background: Gait disorders in PD are varied and complex.  Even…
  • 2017 International Congress

    The 3-step clinical prediction tool for falls in Parkinson’s disease: can it be used as a self-assessment measure?

    L. Mewburn, N. Allen, R. Adams, C. Canning (Lidcombe, Sydney, Australia)

    Objective: To determine if people with Parkinson’s disease (PD) are able to estimate their gait speed relative to a threshold speed of 1.1 m/s. Background:…
  • 2017 International Congress

    Lateralization of fine motor actions in Tourette syndrome persisting through adulthood

    D. Martino, C. Delorme, E. Pelosin, A. Hartmann, Y. Worbe, L. Avanzino (Calgary, AB, Canada)

    Objective: To evaluate whether decreased lateralization of fine motor actions is an endophenotypic trait in adults with Tourette syndrome (TS), and whether it is related…
  • 2017 International Congress

    Rehabilitation program with or without a whey protein-based nutritional support enriched with essential aminoacids and vitamin D in patients with Parkinson’s disease or parkinsonism: study design of a randomized, controlled trial.

    m. barichella, E. Cereda, G. Pinelli, l. Iorio, V. Ferri, g. Frazzitta, E. Cassani, G. Riboldazzi, G. Pezzoli (Milano, Italy)

    Objective: Objective. To evaluate whether the use of a whey protein-based nutritional formula enriched with essential aminoacids – particularly leucine - and vitamin D have…
  • 2017 International Congress

    Noninvasive cerebellar stimulation for adults with cervical dystonia

    A. McCambridge (Sydney, Australia)

    Objective: To examine whether a 5 day treatment period of anodal transcranial direct current stimulation (a-tDCS) over the cerebellum would improve patients’ symptoms and alter…
  • 2017 International Congress

    History and Management of Status Dystonicus

    E. Nerrant, V. GONZALEZ, C. MILESI, T. Roujeau, E. Chan Seng, F. Cyprien, G. Cambonie, P. Coubes, L. CIF (Montpellier, France)

    Objective: To describe a consecutive series of 40 status dystonicus patients, identify major clinical characteristics and to document medical and surgical management. Background: Characteristics and evolution…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley